EDAP TMS (EDAP) Stock Overview
Develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
EDAP Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
EDAP TMS S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$2.42 |
52 Week High | US$3.08 |
52 Week Low | US$1.21 |
Beta | -0.14 |
1 Month Change | 3.86% |
3 Month Change | 59.21% |
1 Year Change | -8.68% |
3 Year Change | -70.88% |
5 Year Change | -47.79% |
Change since IPO | -71.53% |
Recent News & Updates
There Is A Reason EDAP TMS S.A.'s (NASDAQ:EDAP) Price Is Undemanding
Aug 19Is EDAP TMS (NASDAQ:EDAP) Using Debt Sensibly?
Jul 03Recent updates
Shareholder Returns
EDAP | US Medical Equipment | US Market | |
---|---|---|---|
7D | 11.5% | -1.5% | -1.5% |
1Y | -8.7% | -3.4% | 14.4% |
Return vs Industry: EDAP underperformed the US Medical Equipment industry which returned -2.8% over the past year.
Return vs Market: EDAP underperformed the US Market which returned 15.1% over the past year.
Price Volatility
EDAP volatility | |
---|---|
EDAP Average Weekly Movement | 14.5% |
Medical Equipment Industry Average Movement | 8.4% |
Market Average Movement | 6.5% |
10% most volatile stocks in US Market | 17.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EDAP's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: EDAP's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1979 | 310 | Ryan Rhodes | focalone.com |
EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.
EDAP TMS S.A. Fundamentals Summary
EDAP fundamental statistics | |
---|---|
Market cap | US$96.47m |
Earnings (TTM) | -US$24.57m |
Revenue (TTM) | US$73.67m |
Is EDAP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EDAP income statement (TTM) | |
---|---|
Revenue | €63.02m |
Cost of Revenue | €36.25m |
Gross Profit | €26.77m |
Other Expenses | €47.78m |
Earnings | -€21.01m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
Earnings per share (EPS) | -0.56 |
Gross Margin | 42.48% |
Net Profit Margin | -33.35% |
Debt/Equity Ratio | 38.4% |
How did EDAP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/10/16 13:43 |
End of Day Share Price | 2025/10/16 00:00 |
Earnings | 2025/06/30 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
EDAP TMS S.A. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Andrew D'Silva | B. Riley Securities, Inc. |
null null | CG Capital |
Swayampakula Ramakanth | H.C. Wainwright & Co. |